Bolt Biotherapeutics Statistics
Total Valuation
BOLT has a market cap or net worth of $10.09 million. The enterprise value is $9.57 million.
Important Dates
The last earnings date was Tuesday, May 12, 2026, after market close.
| Earnings Date | May 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BOLT has 1.92 million shares outstanding. The number of shares has decreased by -5.32% in one year.
| Current Share Class | 1.92M |
| Shares Outstanding | 1.92M |
| Shares Change (YoY) | -5.32% |
| Shares Change (QoQ) | -2.71% |
| Owned by Insiders (%) | 0.65% |
| Owned by Institutions (%) | 24.75% |
| Float | 1.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.56 |
| Forward PS | 2.66 |
| PB Ratio | 0.51 |
| P/TBV Ratio | 0.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.47 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.51, with a Debt / Equity ratio of 1.13.
| Current Ratio | 3.51 |
| Quick Ratio | 3.12 |
| Debt / Equity | 1.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -88.79% and return on invested capital (ROIC) is -33.13%.
| Return on Equity (ROE) | -88.79% |
| Return on Assets (ROA) | -28.12% |
| Return on Invested Capital (ROIC) | -33.13% |
| Return on Capital Employed (ROCE) | -74.03% |
| Weighted Average Cost of Capital (WACC) | 3.22% |
| Revenue Per Employee | $282,565 |
| Profits Per Employee | -$1.29M |
| Employee Count | 23 |
| Asset Turnover | 0.10 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.59% in the last 52 weeks. The beta is 1.10, so BOLT's price volatility has been similar to the market average.
| Beta (5Y) | 1.10 |
| 52-Week Price Change | -18.59% |
| 50-Day Moving Average | 4.73 |
| 200-Day Moving Average | 5.18 |
| Relative Strength Index (RSI) | 58.19 |
| Average Volume (20 Days) | 28,015 |
Short Selling Information
The latest short interest is 6,999, so 0.36% of the outstanding shares have been sold short.
| Short Interest | 6,999 |
| Short Previous Month | 22,704 |
| Short % of Shares Out | 0.36% |
| Short % of Float | 0.40% |
| Short Ratio (days to cover) | 0.26 |
Income Statement
In the last 12 months, BOLT had revenue of $6.50 million and -$29.58 million in losses. Loss per share was -$16.34.
| Revenue | 6.50M |
| Gross Profit | -22.03M |
| Operating Income | -30.12M |
| Pretax Income | -29.58M |
| Net Income | -29.58M |
| EBITDA | -29.02M |
| EBIT | -30.12M |
| Loss Per Share | -$16.34 |
Full Income StatementBalance Sheet
The company has $22.89 million in cash and $22.31 million in debt, with a net cash position of $584,000 or $0.30 per share.
| Cash & Cash Equivalents | 22.89M |
| Total Debt | 22.31M |
| Net Cash | 584,000 |
| Net Cash Per Share | $0.30 |
| Equity (Book Value) | 19.82M |
| Book Value Per Share | 10.32 |
| Working Capital | 18.41M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$34.51 million and capital expenditures -$72,000, giving a free cash flow of -$34.58 million.
| Operating Cash Flow | -34.51M |
| Capital Expenditures | -72,000 |
| Depreciation & Amortization | 1.10M |
| Net Borrowing | n/a |
| Free Cash Flow | -34.58M |
| FCF Per Share | -$18.00 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -463.44% |
| Pretax Margin | -455.15% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BOLT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.32% |
| Shareholder Yield | 5.32% |
| Earnings Yield | -291.27% |
| FCF Yield | -340.51% |
Analyst Forecast
The average price target for BOLT is $41.00, which is 680.73% higher than the current price. The consensus rating is "Buy".
| Price Target | $41.00 |
| Price Target Difference | 680.73% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 1.18% |
| EPS Growth Forecast (5Y) | 18.03% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 9, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Jun 9, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |
